Delving into the Latest Updates on Taiwan Biotech Co. Ltd. with Synapse

Overview

Tags

Urogenital Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

β2-adrenergic receptor(Beta-2 adrenergic receptor)	1

This study is to explore the optimization of anti-onychomycosis patch with various formulation contents (three patch groups: 3%, 6% and 8% of terbinafine (contains 3-mg, 6-mg and 8-mg/patch terbinafine, respectively) combined with fixed 2% ketoconazole (contains 2-mg ketoconazole/patch) and its safety profile.

Start Date01 Apr 2012

Sponsor / Collaborator

Taiwan Biotech Co. Ltd.

NCT00262184 / Unknown statusNot ApplicableIIT

A Taiwan Isoflavone Multicenter Study (TIMS)

Consumption of soy-based foods is associated with a number of health benefits, including lower risk of cardiovascular disease, breast and prostate cancer, attenuated menopausal symptoms and prevention of bone loss with age.
In order to investigate the effect of isoflavone on bone mineral density (BMD) and in Taiwan women with postmenopausal osteopenia, a Taiwan Isoflavone Multicentric Enrollment Study (TIMS) is designed.

Start Date01 Dec 2004

Sponsor / Collaborator

Taiwan Biotech Co. Ltd.

[+1]

100 Clinical Results associated with Taiwan Biotech Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Taiwan Biotech Co. Ltd.

Login to view more data

2

Literatures (Medical) associated with Taiwan Biotech Co. Ltd.

Proceedings of the International Symposium on Controlled Release of Bioactive Materials

Development of an albuterol transdermal drug delivery system

Author: Chen, S.J. ; Cheng, C.H. ; Jiang, T.S. ; Kuo, C.C.

A matrix-type albuterol transdermal delivery patch was evaluated for its suitability by in vitro skin permeation and animal toxicity studies.The system delivered the drug efficiently with good skin tolerance.

Sustainability

Towards Sustainable Business Model Innovation for the Pharmaceutical Industry

Author: Chuang, Li-Min ; Liu, Te-Hui ; Lee, Yu-Po

This study examines pharmaceutical companies in the context of BMI. The purpose is to develop an SBM for the pharmaceutical industry and then to validate the causal relationships of the variables in such a business model. This study used purposive sampling by issuing questionnaires to 12 companies. The research consisted of the following four studies: Study 1: construction of dimension conceptualization. The conceptualization of BMI consists of three dimensions, i.e., technological, social, and organizational. Study 2 and study 3 are about process development and the construction of a unique BM. Study 2 explores the evolution of innovations in an SBM on the basis of a balance scorecard. Study 3 develops a unique SBM by referring to a focus group comprised of senior executives. Study 4: model validation. This stage is about the synthesis of research frameworks in the literature on BMI and an empirical study on the causal relationships in the context of SBMI.

100 Deals associated with Taiwan Biotech Co. Ltd.

Login to view more data

100 Translational Medicine associated with Taiwan Biotech Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Ritodrine Hydrochloride ( β2-adrenergic receptor )	Obstetric Labor, Premature More	Approved
Ketoconazole/Terbinafine ( CYP51A1 x SQLE )	Onychomycosis More	Pending